bethesda < better < bevacizumab

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 28.
[0-20] [0 - 20][0 - 28][20-27][20-40]

Ident.	Authors (with country if any)	Title
000035 (2013)	T. Witte [Allemagne]	Methotrexat als Kombinationspartner bei TNF-Inhibitoren und Tocilizumab
000049 (2012)	Hubert De Boysson [France] ; Jérome Février [France] ; Amélie Nicolle [France] ; Christophe Auzary [France] ; Loïk Geffray [France]	Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence
000203 (2011)	K. Krüger [Allemagne]	Kombinationsbehandlung von Methotrexat mit DMARDs oder Biologika – Aktueller Stand
000214 (2012)	Fatma Alibaz-Oner [Turquie] ; Sibel Zehra Aydin [Turquie] ; Haner Direskeneli [Turquie]	Advances in the diagnosis, assessment and outcome of Takayasu’s arteritis
000234 (2012)	G. Lippi [Italie] ; G. Targher [Italie]	Optimal therapy for reduction of lipoprotein(a)
000278 (2013)	Frédéric Perros [France] ; Marc Humbert [France] ; Sylvia Cohen-Kaminsky [France]	Hypertension artérielle pulmonaire
000279 (2010)	Arnd Heiligenhaus [Allemagne] ; Stephan Thurau [Allemagne] ; Maren Hennig [Allemagne] ; Rafael S. Grajewski [Allemagne] ; Gerhild Wildner [Allemagne]	Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease
000536 (2009)	Katalin Eder [Hongrie] ; Noemi Baffy [Hongrie] ; Andras Falus [Hongrie] ; Andras K. Fulop [Hongrie]	The major inflammatory mediator interleukin-6 and obesity
000554 (2013)	K. Kume ; K. Amano ; K. Hatta ; H. Ohta [Japon]	THU0109 Treating to target ultrasound with clinical remission better effects than clinical remission in RRP
000670 (2013)	A. Liakos [Royaume-Uni] ; M. Batley [Royaume-Uni] ; T. Hammond [Royaume-Uni] ; A. Saha [Royaume-Uni] ; P. Shrestha [Royaume-Uni] ; A. Keough [Royaume-Uni]	AB0593 Subcutaneous methotrexate is more efficacious and better tolerated than oral methotrexate: The experience of a large group of patients in the rheumatology department of a district general hospital
000701 (2008)	B. Manger [Allemagne]	Der adulte Morbus Still
000852 (2013)	T. Kojima ; K. Funahashi ; N. Takahashi ; D. Kato ; H. Matsubara ; Y. Hattori ; Y. Yabe [Japon] ; N. Ishiguro	THU0124 Importance of monitoring of C-reactive protein level to predict achievement of better clinical outcome during treatment with tocilizumab in patients with rheumatoid arthritis
000880 (2012)	Metin Isik [Turquie] ; Burcin Halacli [Turquie] ; Özgür Atmaca [Turquie] ; Sezgin Etgül [Turquie] ; Smail Do An [Turquie] ; Levent K L Nç [Turquie] ; Meral Çalgüneri [Turquie]	Triple DMARD combination for rheumatoid arthritis resistant to methotrexate and steroid combination: a single-center experience
000999 (2013)	M. Harigai ; S. Inokuma [Japon] ; N. Ishiguro ; J. Ryu ; T. Takeuchi [Japon] ; S. Takei ; Y. Tanaka ; H. Yamanaka ; Y. Sano [Japon] ; H. Yaguramaki [Japon] ; T. Koike [Japon]	SAT0120 Characteristics Associated with Better Effectiveness and Safety in Rheumatoid Arthritis Patients Treated with Intravenous Tocilizumab: Results from Full Analysis of All-Patient Postmarketing Surveillance in Japan
000A16 (2013)	S. Manders [Pays-Bas] ; W. Kievit [Pays-Bas] ; T. Jansen [Pays-Bas] ; J. Stolk ; H. Visser ; R. Bos ; M. Van De Laar [Pays-Bas] ; P. Van Riel [Pays-Bas]	OP0069 Significantly Better Results for TNFI Combination Therapy with MTX Than TNFI Mono- and Combination Without MTX Therapy in Patients with RA: Results from the Dream Registry
000A34 (2010)	Guenther Haberhauer [Autriche] ; Christoph Strehblow [Autriche] ; Peter Fasching [Autriche]	Observational study of switching anti-TNF agents in ankylosing spondylitis and psoriatic arthritis versus rheumatoid arthritis
000C66 (2012)	K. Minden [Allemagne] ; M. Niewerth [Allemagne]	Rheumakranke Kinder und Jugendliche
000C75 (2011)	Richard Charles John Campbell [Royaume-Uni, Niger] ; Michael Batley [Royaume-Uni] ; Anthony Hammond [Royaume-Uni] ; Fowzia Ibrahim [Royaume-Uni] ; Gabrielle Kingsley [Royaume-Uni] ; David L. Scott [Royaume-Uni]	The impact of disease activity, pain, disability and treatments on fatigue in established rheumatoid arthritis
000D21 (2006)	Hiok Hee Chng [Singapour]	Management of systemic lupus erythematosus in the coming decade: potentials and challenges
000E50 (2010)	R. Fischer-Betz [Allemagne] ; E. Gromnica-Ihle [Allemagne]	Schwangerschaft bei entzündlich-rheumatischen Erkrankungen
000E55 (2012)	Gary Hudes [États-Unis] ; Scott T. Tagawa [États-Unis] ; Young E. Whang [États-Unis] ; Ming Qi [États-Unis] ; Xiang Qin [États-Unis] ; Thomas A. Puchalski [États-Unis] ; Manjula Reddy [États-Unis] ; Mark Cornfeld [États-Unis] ; Mario Eisenberger [États-Unis]	A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "better" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "better" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    better
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021